Related Experiment Video
Updated: Aug 21, 2026

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
Published on: September 22, 2017
Dysthyroid optic neuropathy (DON)
1Neuro-ophthalmology Unit, British Hospital of Buenos Aires, Finochietto 1700, C1275 AAJ, Buenos Aires, Argentina. rebner@intramed.net.ar
Abstract:
Dysthyroid Optic Neuropathy (DON) affects a small percentage of patients with Graves disease, but, when it occurs, it can cause significant and permanent loss of vision. DON is treatable if recognized early. Systemic steroids can be effective, but may cause side affects. Orbital injection of steroids may play a role in selected patients. Orbital radiation has a more permanent effect and has gained wide acceptance as a relatively non-invasive method of reversing DON. Surgery to decompress crowded orbits has been used for years and continues to be a viable approach for those patients with optic neuropathy, especially when there is significant proptosis. Optic nerve decompression can also be achieved through a transethmoidal approach.
Related Concept Videos
Diabetic Retinopathy
Glaucoma: Overview
Hypothyroidism II: Pathophysiology
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Photoreceptors and Visual Pathways
Hyperthyroidism II: Pathophysiology
